Stay Informed

Pfizer News

February 1, 2011
Pfizer Issues Statement On Voluntary Recall

February 1, 2011
Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral®-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Possibility Of Inexact Tablet Counts Or Out Of Sequence Tablets

January 31, 2011
Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance

January 30, 2011
Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

January 27, 2011
U.S. Food And Drug Administration Approves Pfizer's INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)

January 27, 2011
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia

January 26, 2011
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer's Care

January 23, 2011
MS LifeLines® Earns J.D. Power and Associates Call Center Certification for Customer Service Excellence in Providing Support Services to the MS Community

January 17, 2011
Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer's Disease

January 10, 2011
Introducing nutritionpossible.com – A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health

January 3, 2011
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

December 30, 2011
Pfizer Receives FDA Approval to Extend Use of Prevnar 13® for Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older

December 22, 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms

December 22, 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms

December 20, 2011
Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts

December 20, 2011
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis

December 16, 2011
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (pregabaline) Capsules CV In Restless Legs Syndrome

December 16, 2011
Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World's Poorest Countries

December 13, 2011
New Survey Reveals Top Misperceptions Parents Have When Treating Their Child's Fever

December 12, 2011
Pfizer Elects CEO Ian Read As Chairman Of The Board

December 12, 2011
Pfizer Declares A 22-Cent First-Quarter 2012 Dividend

December 9, 2011
Jon Bon Jovi Reveals His True Advil® Story

December 8, 2011
The Advil® Congestion Relief Project Tackles Congestion in Chicago, the Country's #1 City for Traffic Congestion*

December 7, 2011
FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC) To Be Favorable

December 5, 2011
Pfizer's Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients

December 2, 2011
Pfizer Completes Acquisition of Excaliard

December 1, 2011
Pfizer Completes Acquisition of Ferrosan Consumer Health's Business

November 30, 2011
New Research Initiative Examines Economic Impact of Smoke-free Policies on Restaurants and Bars

November 29, 2011
FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

November 22, 2011
Pfizer to Acquire Excaliard Pharmaceuticals

November 21, 2011
Pfizer And MIT Break Ground On New Research Units In Kendall Square

November 21, 2011
Pfizer Announces European Medicines Agency Acceptance Of Regulatory Submission For Tofacitinib For The Treatment Of Rheumatoid Arthritis

November 18, 2011
Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program

November 17, 2011
Pfizer's Vyndaqel® (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

November 16, 2011
The Advil® Congestion Relief Project Hits the Road to Relieve Congestion in Communities

November 14, 2011
Kathryn Joosten Speaks Out About Lung Cancer Profiles; 'Desperate' to Share Her Personal Lung Cancer Story to Help Others

November 13, 2011
New Data Presented On Phase 3 Trial Of ELIQUIS® (apixaban) In The Prevention Of Venous Thromboembolism In Patients With Acute Medical Illness

November 8, 2011
Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency

November 7, 2011
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology

November 5, 2011
Treatment with Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients with Moderately Active Disease

November 1, 2011
Pfizer Reports Third-Quarter 2011 Results

Pfizer Articles

New Website Guides Consumers on Nutritional, Lifestyle Choices (February 2012)

Advil Relieves Community Congestion Across the US (February 2012)

Company Supports Online Alzheimer's Disease Health Center (January 2012)

Caregiver Initiative Nears First Anniversary (January 2012)

Emmy-Winning Actress Turns Spotlight on Lung Cancer (January 2012)

Company's Pro Bono Work Helps Keep Sea Life Healthy (December 2011)

Company Launches Pfizer Health YouTube Channel (November 2011)

Former Warner-Lambert CEO Describes First Year With Alzheimer's (November 2011)

Reaching Out to Retirees (Pfizer Plus July 2011 - registered users only)

Retiree Feedback: In Focus (Pfizer Plus July 2011 - registered users only)

What is the Retiree Advisory Committee? (Pfizer Plus July 2011 - registered users only)

Baby Kangaroo Documentary Has Colleague Hopping (April 2011)

Pfizer Launches Orphan and Genetic Diseases Unit (June 2010)

We Came. We Listened. We Heard. (Pfizer Plus July 2010 - registered users only)

Looking Back on 2009, Ahead to 2010 (Pfizer Plus 4Q 2009 - registered users only)

Pfizer and Wyeth Are One (Pfizer Plus 4Q 2009 - registered users only)

Pfizer Delivers a Solid Performance (Pfizer Plus 4Q 2009 - registered users only)

Pfizer Expands Its Mission, Establishes New Core Commitments (Pfizer Plus 4Q 2009 - registered users only)

Refreshed Logo Conveys Change, Momentum (Pfizer Plus 4Q 2009 - registered users only)

Fall Signals Annual Benefits Enrollment and
Much More (Pfizer Plus 3Q 2009 - registered users only)

Pfizer Continues to Execute on Its Financial and Strategic Commitment (Pfizer Plus 3Q 2009 - registered users only)

Wyeth Acquisition Planning Update: Kindler Shares
His Thoughts (Pfizer Plus 3Q 2009 - registered users only)

Your Input Shapes Our Planning (Pfizer Plus 2Q 2009 - registered users only)

Creating The World's Premier Biopharmaceutical Company: Wyeth Acquisition Planning Update (Pfizer Plus 2Q 2009 - registered users only)

Pfizer Reports First-Quarter 2009 Results (Pfizer Plus 2Q 2009 - registered users only)

Spring Brings Changes to Plus In Print and Plus Online (Pfizer Plus 1Q 2009 - registered users only)

Pfizer Along the Path To the Future — Wyeth Acquisition (Pfizer Plus 1Q 2009 - registered users only)

Pfizer Reports 2008 Financial Objectives, Provides Guidance for 2009 (Pfizer Plus 1Q 2009 - registered users only)

In an Industry First, Pfizer Launches New Medicine Safety Web Site

For past Plus Pfizer articles in print, please visit the Plus newsletters archive section.